Introducing TROMATZ™: An Innovative Device for Nasal Inflammation Treatment

TROMATZ™ Bio-Current Device Set to Transform Nasal Health

In a groundbreaking move, Japanese company Tromatz Inc., based in Koto City, Tokyo, is set to launch the TROMATZ™ Bio-Current Device aimed specifically at combating nasal inflammation. This innovative healthcare solution utilizes advanced bio-technology to enhance sinus health and is scheduled for release in early August 2026 at a retail price of 68,000 yen (excluding tax).

What is the TROMATZ™ Bio-Current Device?

The TROMATZ™ device is a product of the ingenious TROMATZ™ technology developed by Dr. Kim Young Wook, co-founder of Tromatz Inc. This bio-current (microcurrent) electronic therapy device employs a unique method that generates high-frequency microcurrents to detach and eliminate biofilms in the nasal cavity, effectively suppressing bacterial growth and alleviating inflammation.

Notably, the device operates at a capacity of 100 µC and a frequency of 10 MHz, employing a simultaneous application of both direct and alternating current to produce a therapeutic effect. By activating the cells in inflamed areas, it promotes healing and regeneration of the mucosal membranes, making it particularly effective for individuals suffering from allergic rhinitis and sinusitis. Furthermore, Tromatz holds an impressive portfolio of 165 related patents, showcasing its commitment to innovation and excellence in medical technology.

The Scientific Authority Behind the Device

The development of the TROMATZ™ Bio-Current Device has not only been backed by extensive research but is also supervised by Dr. T.H. Lee, a prominent professor at Stanford University and a director of the Korean Society of Otorhinolaryngology. Together with his team at Ulsan University, Dr. Lee has conducted rigorous validation experiments, ensuring the device's efficacy and reliability.

Dr. T.H. Lee has an impressive background in facial plastic surgery and sleep surgery, with numerous accolades including awards from the South Korean government for his contributions to medical research. His expertise lends immense credibility to the TROMATZ™ device, making it a trusted solution for those in need of effective sinus relief.

Clinical Evidence and Effectiveness

Clinical trials conducted at Ulsan University have shown promising results, indicating that the TROMATZ™ device can significantly improve nasal symptoms. The Total Nasal Symptom Score (TNSS) demonstrated a remarkable improvement of 43%, while the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) saw an enhancement of 44%. These statistics highlight the potential of the device to enhance users' overall quality of life, allowing them to leave behind the discomfort associated with nasal conditions.

Comprehensive Certifications

To ensure user safety and device performance, the TROMATZ™ Bio-Current Device has garnered various certifications. It is compliant with the Federal Communications Commission (FCC) standards in the United States, the CE mark in Europe indicating conformity with health and safety standards, and ISO 13485 certification for medical device quality management systems. Moreover, it follows South Korea’s GMP standards for medical device manufacturing and quality control.

The Future of Healthcare with TROMATZ™

As Tromatz Inc. continues to innovate, the applications of TROMATZ™ technology expand beyond just nasal health. Future device developments include a toothbrush for bacteria suppression and enhanced oral health, a beauty device for skin rejuvenation, and even a hair growth brush aimed at revitalizing hair follicles. The potential of this technology is vast and could redefine health regimes across multiple domains.

Overall, the launch of the TROMATZ™ Bio-Current Device represents a significant advance in healthcare technology tailored to alleviate nasal inflammation. With scientific validation and an innovative foundation, this device promises to greatly enhance the lives of those who suffer from various nasal conditions. Keep an eye on Tromatz Inc. as they trailblaze into the future of healthcare innovation.

For more information, visit Tromatz’s official website here.